Impact Biomedical Inc IBO

$2.68 -0.48 (-15.15%)

Valuation

Market cap
26,971,000
Revenue TTM
$30,000
Net income TTM
$-11,840,000
PE ratio
0.00
Forward PE
—
Profit margin
-39,466.67%
Debt to equity
0.00

Trading

Volume
10,200
Avg volume
15,553
Day's range
$2.43 – $3.21
Shares out
8,539,000
Stochastic %K
10%
Beta
2.74
Analysts
Strong Buy
Price target
—

Price

Company profile

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflamma...

Show more

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Industry
Biotechnology
Sector
Healthcare
Phone
281 415 6576
Website
https://www.impactbiomedinc.com
Address
1400 Broadfield Blvd., Suite 130, Houston, United States

Latest news

Stocktwits

johannn Oct 16, 9:25 AM
$AEI $DSS $IBO $HWH Since the lead swindler, that sewer rat Chan, has stolen the majority of the shares from the sister companies—while the share values ​​remain recorded in the books—it is to be hoped that the house of cards consisting of the other fake companies will collapse. https://www.sec.gov/Archives/edgar/data/771999/000149315226041836/xslSCHEDULE_13D_X02/primary_doc.xml Yet another wreck: https://finance.yahoo.com/quote/40V.SI/ and another: https://finance.yahoo.com/quote/VEII/ and another: https://finance.yahoo.com/quote/SHRG/ and another: https://finance.yahoo.com/quote/HIPH/ There are even more.
0 replies
johannn Oct 16, 8:29 AM
$DSS $IBO $HWH $AEI Here is an update on IBO following the reverse split, covering the period from September 23 through Thursday, October 15. The share price was $6.63 on September 23 and $3.1584 on October 15—a decline of more than 50%. They would have been better off not executing a reverse split, especially since they had received no directive from the NYSE to do so. The only thing these swindlers are capable of is destroying value—though, in truth, this stock never had any real value to begin with. With 93 million new shares entering the market via DSS, the price had simply remained stagnant; yet, these idiots chose to carry out a reverse split, effectively triggering the AI ​​trading algorithms.🕵️‍♂️🕵️‍♂️🥷🥷👨‍🦯👨‍🦯
0 replies
Whiskey1679 Oct 14, 11:28 PM
Movers & Shakers: $JELD $BCDA $SLND $IBO
0 replies
focafoca99 Oct 9, 9:07 PM
$IBO effected a 1-for-12.62 reverse stock split, consolidating 12.62 pre-split shares into one post-split share.
0 replies
johannn Oct 8, 9:19 PM
$AEI $DSS $IBO $HWH What a surprise—or not: a reverse stock split for the empty shell Alset Inc./AEI. https://www.sec.gov/Archives/edgar/data/1750106/000149315226046352/formpre14c.htm
1 replies
johannn Oct 5, 7:10 PM
$DSS $IBO $AEI A new Amendment No. 1 from the Zoar scammer gang today. https://www.sec.gov/ix?doc=/Archives/edgar/data/0002078148/000149315226045654/formf-4a.htm
0 replies
johannn Sep 25, 9:48 AM
$DSS $IBO $AEI $HWH DSS has sold a few more IBO shares; that is a clear sign of a lack of confidence. Or are these just remnants that had to be reported following share price manipulations? https://www.sec.gov/Archives/edgar/data/1834105/000149315226044207/xslF345X06/ownership.xml The SEC will likely approve everything again, and probably the reverse split with another con artist, too.
1 replies
johannn Sep 23, 11:56 AM
$IBO $DSS $AEI $PRPH The day has arrived for IBO’s reverse stock split—an indication that the stock is worthless; a reverse split won’t change that fact either. Just look at PRPH. On September 14, 2026, the Company released a press release relating to its proposed Reverse Stock Split (the “Reverse Split”), which will become effective at 12:01 a.m., Eastern Time, on September 23, 2026. https://www.sec.gov/Archives/edgar/data/1834105/000149315226042635/form8-k.htm
0 replies